Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TMEM55B
is first identified as phosphatidylinositol-4,5-P24-phosphatases (PtdIns-4,5-P24-phosphatases) that catalyse dephosphorylation of PtdIns-4,5-P2 to PtdIns-5-P. We demonstrate for the first time that
TMEM55B
is phosphorylated by Erk/MAPK and that this mechanism participates in regulation of lysosomal clustering. Exposure of RAW264.7 macrophages to various stimuli induces phosphorylation of
TMEM55B
on Ser76 and Ser169, sites corresponding to consensus sequences (PX(S/T)P) for phosphorylation by MAPK. Of these stimuli, Toll-like receptor ligands most strongly induce
TMEM55B
phosphorylation, and this is blocked by the
MEK1
/2 inhibitor U0126. However, phosphorylation does not impact intrinsic phosphatase activity of
TMEM55B
.
TMEM55B
has recently been implicated in starvation induced lysosomal translocation. Amino acid starvation induces perinuclear lamp1 clustering in RAW264.7 macrophages, which was attenuated by shRNA-mediated knock-down or CRISPR/Cas9-mediated knock-out of
TMEM55B
. Cells exposed to U0126 also exhibit attenuated lamp1 clustering. Overexpression of
TMEM55B
but not TMEM55A notably enhances lamp1 clustering, with
TMEM55B
mutants (lacking phosphorylation sites or mimicking the phosphorylated state) exhibiting lower and higher efficacies (respectively) than wild-type
TMEM55B
. Collectively, results suggest that phosphorylation of
TMEM55B
by Erk/MAPK impacts lysosomal dynamics.
...
PMID:Phosphorylation of TMEM55B by Erk/MAPK regulates lysosomal positioning. 3132 83